Network pharmacology analysis uncovers the mechanism of Shudihuang-Shanzhuyu herb pair in prevention and treatment of diabetic osteoporosis via PI3K/AKT pathway
Si-jing Hu , Gao-ce Chen , Fang-yuan Wang , Ying-qi Fang , Si-qi Wang , Zi-le Song , Zi-hui Zhao , Quan-long Zhang , Xiong-yu Meng , Qiao-yan Zhang , Lu-ping Qin
{"title":"Network pharmacology analysis uncovers the mechanism of Shudihuang-Shanzhuyu herb pair in prevention and treatment of diabetic osteoporosis via PI3K/AKT pathway","authors":"Si-jing Hu , Gao-ce Chen , Fang-yuan Wang , Ying-qi Fang , Si-qi Wang , Zi-le Song , Zi-hui Zhao , Quan-long Zhang , Xiong-yu Meng , Qiao-yan Zhang , Lu-ping Qin","doi":"10.1016/j.jep.2025.119581","DOIUrl":null,"url":null,"abstract":"<div><h3>Ethnopharmacological relevance</h3><div>Diabetic osteoporosis (DOP) is a complication of diabetes characterized by reduced bone mass and increased fracture risk. Shudihuang (Rehmanniae Radix Praeparata, RR) and Shanzhuyu (Corni Fructus, CF) form a classical herb pair known as RR-CF in traditional Chinese medicine (TCM) for nourishing Yin and tonifying the kidney, and have long been used for the treatment of diabetes and OP in TCM clinical practise. However, the potential mechanism underlying the preventive and therapeutic effects of RR-CF on DOP has not been clarified.</div></div><div><h3>Aim of the study</h3><div>This study aimed to explore the protective effects of RR-CF on bone loss caused by diabetes and elucidate the underlying action mechanism.</div></div><div><h3>Methods</h3><div>The chemical constituents in RR-CF were detected using UPLC-Q-Exactive-MS. Type 1 diabetes mellitus (T1DM) was induced in rats by injecting streptozotocin, followed by administration of RR-CF extracts for 10 weeks. Bone mineral density, morphometric bone parameters, and serum and urine biochemical markers were analyzed using Micro-CT and ELISA kits. An <em>in vitro</em> osteoblastic injury model was constructed by subjecting MC3T3-E1 cells to high glucose and used to evaluate the effects of the RR-CF on osteoblastic bone formation. The anti-DOP mechanism of RR-CF was explored by network pharmacologic analysis and then verified in osteoblasts damaged by high glucose.</div></div><div><h3>Results</h3><div>A total of 56 compounds were identified in RR-CF. Treatment with RR-CF extracts improved the bone microstructure and mineral density in the T1DM rats, and decreased the level of urine deoxypyridinoline and serum carboxyl terminal peptide of type I procollagen. The network pharmacology analysis identified cornuside, hydroxygenkwanin, acteoside, catalpol and echinacoside as the potential active components of RR-CF against DOP by interacting with the key node genes such as AKT1, EGFR, TNF, MMP9 and HSP90α. Further GO and KEGG enrichment analysis suggested that the therapeutic effects of RR, CF and RR-CF seemed to be related to the regulation of hormones, inflammation and metabolism, as well as signaling transductions of PI3K-AKT, IL-17, TNF, MAPK and estrogen signaling pathways. RR-CF promoted osteoblast differentiation and bone formation in the MC3T3-E1 cells by regulating PI3K-AKT signaling pathway.</div></div><div><h3>Conclusion</h3><div>RR-CF herb pair inhibits bone loss caused by high glucose by regulating the PI3K-AKT signaling pathways.</div></div>","PeriodicalId":15761,"journal":{"name":"Journal of ethnopharmacology","volume":"345 ","pages":"Article 119581"},"PeriodicalIF":5.4000,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of ethnopharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S037887412500265X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Ethnopharmacological relevance
Diabetic osteoporosis (DOP) is a complication of diabetes characterized by reduced bone mass and increased fracture risk. Shudihuang (Rehmanniae Radix Praeparata, RR) and Shanzhuyu (Corni Fructus, CF) form a classical herb pair known as RR-CF in traditional Chinese medicine (TCM) for nourishing Yin and tonifying the kidney, and have long been used for the treatment of diabetes and OP in TCM clinical practise. However, the potential mechanism underlying the preventive and therapeutic effects of RR-CF on DOP has not been clarified.
Aim of the study
This study aimed to explore the protective effects of RR-CF on bone loss caused by diabetes and elucidate the underlying action mechanism.
Methods
The chemical constituents in RR-CF were detected using UPLC-Q-Exactive-MS. Type 1 diabetes mellitus (T1DM) was induced in rats by injecting streptozotocin, followed by administration of RR-CF extracts for 10 weeks. Bone mineral density, morphometric bone parameters, and serum and urine biochemical markers were analyzed using Micro-CT and ELISA kits. An in vitro osteoblastic injury model was constructed by subjecting MC3T3-E1 cells to high glucose and used to evaluate the effects of the RR-CF on osteoblastic bone formation. The anti-DOP mechanism of RR-CF was explored by network pharmacologic analysis and then verified in osteoblasts damaged by high glucose.
Results
A total of 56 compounds were identified in RR-CF. Treatment with RR-CF extracts improved the bone microstructure and mineral density in the T1DM rats, and decreased the level of urine deoxypyridinoline and serum carboxyl terminal peptide of type I procollagen. The network pharmacology analysis identified cornuside, hydroxygenkwanin, acteoside, catalpol and echinacoside as the potential active components of RR-CF against DOP by interacting with the key node genes such as AKT1, EGFR, TNF, MMP9 and HSP90α. Further GO and KEGG enrichment analysis suggested that the therapeutic effects of RR, CF and RR-CF seemed to be related to the regulation of hormones, inflammation and metabolism, as well as signaling transductions of PI3K-AKT, IL-17, TNF, MAPK and estrogen signaling pathways. RR-CF promoted osteoblast differentiation and bone formation in the MC3T3-E1 cells by regulating PI3K-AKT signaling pathway.
Conclusion
RR-CF herb pair inhibits bone loss caused by high glucose by regulating the PI3K-AKT signaling pathways.
期刊介绍：
The Journal of Ethnopharmacology is dedicated to the exchange of information and understandings about people''s use of plants, fungi, animals, microorganisms and minerals and their biological and pharmacological effects based on the principles established through international conventions. Early people confronted with illness and disease, discovered a wealth of useful therapeutic agents in the plant and animal kingdoms. The empirical knowledge of these medicinal substances and their toxic potential was passed on by oral tradition and sometimes recorded in herbals and other texts on materia medica. Many valuable drugs of today (e.g., atropine, ephedrine, tubocurarine, digoxin, reserpine) came into use through the study of indigenous remedies. Chemists continue to use plant-derived drugs (e.g., morphine, taxol, physostigmine, quinidine, emetine) as prototypes in their attempts to develop more effective and less toxic medicinals.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
